FDA Issues Class I Recall for COVID-19 At-Home Tests
This Class I recall is for certain COVID-19 at-home test kits containing liquid solution that may be contaminated with bacteria.
Read MorePosted by Melanie Hamilton-Basich | May 31, 2023 | Covid 19 |
This Class I recall is for certain COVID-19 at-home test kits containing liquid solution that may be contaminated with bacteria.
Read MorePosted by Chris Wolski | May 29, 2023 | Cancer |
Delays in cancer screening during the COVID-19 pandemic will likely cause a significant increase in cancer cases.
Read MorePosted by Chris Wolski | May 25, 2023 | Molecular Diagnostics |
The award through the NIH’s RADx Tech program, will support Domus Diagnostics’ at-home molecular test for clinical trial readiness.
Read MorePosted by Chris Wolski | May 11, 2023 | Covid 19 |
The U.S. Food and Drug Administration (FDA) granted marketing authorization to two COVID-19 serology tests.
Read MorePosted by Melanie Hamilton-Basich | May 1, 2023 | Molecular Diagnostics |
An advanced DNA sequencing technique, or molecular autopsy, was able to determine why a young child died after a relatively mild infection, when a traditional autopsy could not.
Read More